IIPR-PA — Innovative Industrial Properties, Inc.

Summary of IIPR-PA Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Total Revenues: $69 million, a 3.5% increase from Q4 2025.
• Adjusted Funds from Operations (AFFO): $53.4 million, or $1.88 per share, consistent with the previous quarter.
• Liquidity: Approximately $177 million, consisting of $89 million in cash and $87.5 million available under revolving credit facilities.
• Debt Metrics: Debt service coverage ratio exceeding 11x and net debt to adjusted EBITDA at 1.1x.

2. Strategic Updates and Business Highlights

• The rescheduling of cannabis from Schedule I to Schedule III is seen as a significant regulatory milestone, potentially enhancing the operational environment for medical cannabis operators.
• IIPR raised $128 million in gross proceeds year-to-date and is pursuing an additional $130 million in financing to address upcoming bond maturities and support growth.
• The company signed new leases totaling approximately 331,000 square feet across four properties, indicating strong demand for its facilities.
• IIPR has made progress in resolving tenant issues, including reaching agreements with former tenants PharmaCann and Gold Flora.

3. Forward Guidance and Outlook

• The management team remains optimistic about the cannabis market's future, particularly with the potential for expanded medical programs and the upcoming administrative hearings on cannabis rescheduling.
• The company is focusing on refinancing its unsecured debt and completing its commitment to IQHQ before pursuing further growth opportunities.
• IIPR expects to continue benefiting from the strengthening cannabis industry and is positioned to capitalize on new leasing opportunities.

4. Bad News, Challenges, or Points of Concern

• The company faces ongoing macroeconomic challenges, including inflation and elevated interest rates, which could impact operations.
• There are still unresolved tenant issues, particularly with Battle Green, which defaulted on lease obligations.
• The uncertainty surrounding the timeline and outcomes of the administrative hearings could pose risks to the anticipated benefits of rescheduling.

5. Notable Q&A Insights

• Management indicated that while the rescheduling is a positive development, it does not address interstate commerce or banking issues, which remain significant hurdles for the cannabis industry.
• There is cautious optimism regarding future credit issues for tenants, as 280E relief may improve their financial situations, but management acknowledged that risks inherent to business operations will persist.
• The company is exploring acquisition opportunities in the cannabis sector, particularly in states with expanding medical programs, while prioritizing the completion of refinancing efforts.

Overall, IIPR demonstrated a solid financial performance in Q1 2026, with strategic initiatives aimed at capitalizing on a changing regulatory landscape and addressing tenant challenges. However, macroeconomic pressures and unresolved tenant issues remain points of concern.